Year: 2020
Type: article
Abstract: Squalene is the precursor for triterpene-based natural products and steroids-based drugs. It has been widely used as pharmaceutical intermediates and personal care products. The aim of this work is to test the feasibility of engineering Yarrowia lipolytica as a potential host for squalene production. The bottleneck of the pathway was removed by overexpressing native HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase. With the recycling of NADPH from the mannitol cycle, the engineered strain produced about 180.3 mg/L and 188.2 mg/L squalene from glucose or acetate minimal media. By optimizing the C/N ratio, controlling the media pH and mitigating acetyl-CoA flux competition from lipogenesis, the engineered strain produced 502.7 mg/L squalene, a 28-fold increase over the parental strain (17.2 mg/L). This work may serve as a baseline to harness Y. lipolytica as an oleaginous cell factory for sustainable production of squalene or terpenoids-based chemicals and natural products.
Source: Bioresource Technology
Authors: Huan Liu, Fang Wang, Li Deng, Peng Xu
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,739
Awards: Combining metabolic engineering and synthetic biology to engineer natural product synthesis in oleaginous yeast, University of Maryland, Baltimore County - to develop a low-cost artemisinic acid manufacturing process to stabilize the artemisinin market and fight malaria in developing countries, G3607656411, G6785441285
OpenAlex ID: W3047860681
